Intelligence Driven Advisers, LLC Pfizer Inc Transaction History

Intelligence Driven Advisers, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 19, 2022	BUY	$41.32 - $61.25 $164,577 - $243,958	3,983 New	3,983 $226,000
Q1 2020 Sep 04, 2020	SELL	$27.03 - $38.62 $143,421 - $204,917	-5,306 Closed	0 $0
Q4 2019 Sep 04, 2020	BUY	$32.92 - $37.36 $174,673 - $198,232	5,306 New	5,306 $208,000
Q3 2019 Sep 04, 2020	SELL	$32.49 - $42.13 $174,796 - $226,659	-5,380 Closed	0 $0
Q2 2019 Sep 04, 2020	SELL	$36.98 - $41.52 $5,177 - $5,812	-140 Reduced 2.54%	5,380 $233,000
Q1 2019 Sep 04, 2020	BUY	$37.5 - $41.2 $207,000 - $227,424	5,520 New	5,520 $234,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Intelligence Driven Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Intelligence Driven Advisers, LLC with notifications on news.